Table 2. Clinical pathological parameters and expression of CHD1L for prognosis of 191 patients with EC by univariate survival analysis (log-rank test).
| Variable | All cases | Mean survival(months) | P value |
|---|---|---|---|
| Gender | 0.438 | ||
| Female | 50 | 40.8 | |
| Male | 141 | 38.9 | |
| Age at surgery | 0.690 | ||
| <60 | 125 | 39.7 | |
| ≥60 | 66 | 38.8 | |
| Histology type | 0.396 | ||
| Ulcerating-type | 68 | 41 | |
| Medullary-type | 74 | 37.8 | |
| Fungating-type | 38 | 38.2 | |
| Stricture-type | 11 | 43.9 | |
| Clinical stages | 0.000* | ||
| I | 19 | 45.9 | |
| II | 75 | 42.8 | |
| III | 42 | 37.2 | |
| IV | 55 | 30.9 | |
| Differentiation | 0.022* | ||
| Poor | 36 | 29.9 | |
| Mediate | 127 | 34.4 | |
| Well | 27 | 44.4 | |
| Tumor location | 0.306 | ||
| Upper | 27 | 40 | |
| Middle | 140 | 38.35 | |
| Lower | 23 | 44.6 | |
| Tumor size(cm) | 0.669 | ||
| <4 | 39 | 40.3 | |
| ≥4 | 152 | 39.1 | |
| Lymph node metastasis | 0.000* | ||
| None | 90 | 45.6 | |
| <4 | 35 | 40.3 | |
| ≥4 | 66 | 30.33 | |
| CHD1L | 0.001* | ||
| High expression | 86 | 35.2 | |
| Low expression | 105 | 40.6 |
* P < 0.05 was considered significant.